← Dashboard
Oct 28, 2026 08:09 AM ET
Signal
Corporate
GSK Non-GAAP EPS of £0.55 beats by £0.04, revenue of £8.89B beats by £50M; reaffirms FY outlook
GSK beat EPS and revenue estimates while reaffirming full-year outlook.
What changed
GSK beat EPS and revenue estimates while reaffirming full-year outlook.
Why it matters
GSK beat EPS and revenue estimates while reaffirming full-year outlook. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →